Production approval for Larotretinib

Release date: 2024-07-10 14:07:34     Recommended: 386

Larotinib is the first specific targeting drug in the world that only targets a certain tumor regardless of tumor type. It can be used for 17 kinds of tumors, including breast cancer, colorectal cancer, lung cancer, thyroid, etc. Even if conventional therapy is ineffective, corresponding genes can be found through NTRK gene detection, which has a quick effect and a long acting time, and is suitable for adults and children.